Want to see HK:6078 full AI Analyst Report?
6078 Stock Chart & Stats
HK$10.13
HK$0.07(0.70%)
At close: 4:00 PM EDT
HK$10.13
HK$0.07(0.70%)
Day’s Range― - ―
52-Week RangeHK$8.10 - HK$14.79
Previous CloseN/A
Volume725.80K
Average Volume (3M)2.03M
Market Cap
HK$5.77B
Enterprise ValueHK$7.39B
Total Cash (Recent Filing)HK$758.87M
Total Debt (Recent Filing)HK$2.26B
Price to Earnings (P/E)27.7
Beta1.14
Next Earnings
Mar 31, 2027EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend Yield0.39%
Share Statistics
EPS (TTM)0.29
Shares Outstanding618,499,000
10 Day Avg. Volume898,825
30 Day Avg. Volume2,034,422
Financial Highlights & Ratios
PEG Ratio-0.58
Price to Book (P/B)1.02
Price to Sales (P/S)1.72
P/FCF Ratio14.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$15.32Price Target Upside51.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.86
Revenue Forecast (FY)HK$4.17B
Bulls Say, Bears Say
Bulls Say
Strong Multi-year Revenue GrowthSustained revenue expansion indicates that Hygeia is continuing to scale its hospital and medical-services platform. A growing top line can support broader patient reach, improved operating leverage, and additional investment in facilities and care capabilities over the next several quarters.
Manageable Leverage And Expanding Equity BaseModerate leverage and a growing equity base provide financial capacity for continued expansion while limiting balance-sheet strain. This should give Hygeia more flexibility to fund hospital development and absorb operating volatility than a highly indebted healthcare operator.
Improving Operating Cash FlowPositive operating cash flow, together with the 2025 free-cash-flow rebound, shows that the hospital network is generating internal funding from operations. Improving cash generation can support reinvestment and reduce reliance on external financing as the business scales.
Bears Say
Sharp Profitability DeteriorationThe steep decline in net margin materially weakens earnings quality and makes recent revenue growth less valuable to shareholders. Unless profitability recovers, lower earnings conversion could constrain reinvestment, reduce returns, and make performance less consistent over the coming quarters.
Compressed Operating And Gross MarginsMargin compression suggests that growth is currently carrying a heavier cost burden or facing pricing pressure. Persistently lower gross and operating margins would reduce the benefit of scale, limit operating leverage, and leave the company more exposed to further earnings volatility.
Inconsistent Cash ConversionUneven conversion of reported earnings into free cash flow indicates that working-capital movements or reinvestment needs can absorb a meaningful portion of profits. This reduces the reliability of internally generated funding and may limit flexibility for expansion or capital allocation.
Hygeia Healthcare Holdings Co., Ltd. News
6078 FAQ
What was Hygeia Healthcare Holdings Co., Ltd.’s price range in the past 12 months?
Hygeia Healthcare Holdings Co., Ltd. lowest stock price was HK$8.10 and its highest was HK$14.79 in the past 12 months.
What is Hygeia Healthcare Holdings Co., Ltd.’s market cap?
Hygeia Healthcare Holdings Co., Ltd.’s market cap is HK$5.77B.
When is Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date?
Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 177 days.
How were Hygeia Healthcare Holdings Co., Ltd.’s earnings last quarter?
Hygeia Healthcare Holdings Co., Ltd. released its earnings results on Aug 27, 2026. The company reported HK$0.491 earnings per share for the quarter, beating the consensus estimate of HK$0.351 by HK$0.14.
Is Hygeia Healthcare Holdings Co., Ltd. overvalued?
According to Wall Street analysts Hygeia Healthcare Holdings Co., Ltd.’s price is currently Undervalued.
Does Hygeia Healthcare Holdings Co., Ltd. pay dividends?
Hygeia Healthcare Holdings Co., Ltd. pays a Notavailable dividend of HK$0.164 which represents an annual dividend yield of 0.39%. See more information on Hygeia Healthcare Holdings Co., Ltd. dividends here
What is Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate?
Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate is 0.44.
How many shares outstanding does Hygeia Healthcare Holdings Co., Ltd. have?
Hygeia Healthcare Holdings Co., Ltd. has 618,499,000 shares outstanding.
What happened to Hygeia Healthcare Holdings Co., Ltd.’s price movement after its last earnings report?
Hygeia Healthcare Holdings Co., Ltd. reported an EPS of HK$0.491 in its last earnings report, beating expectations of HK$0.351. Following the earnings report the stock price went down -6.91%.
Which hedge fund is a major shareholder of Hygeia Healthcare Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in HK:6078
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hygeia Healthcare Holdings Co., Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Hygeia Healthcare Holdings Co., Ltd.
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
6078 Stock 12 Month Forecast
Average Price Target
HK$15.32
▲(51.26% Upside)
Technical Analysis
Aidigong Maternal & Child Health
―
Jinxin Fertility Group Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―








